Formation Bio was last valued at $1.7B (post-money). It comes from the $372M Series D of Jun 2024. The company is private, so there is no listed share price.
1 valuation. The latest, $1.7B post-money, was set by the Series D in Jun 2024.
A private valuation is the price agreed in one transaction. The Formation Bio valuation of $1.7B is a post-money figure from the Series D dated 1 Jun 2024 — the whole company measured after the $372M raised in that round was already inside it. Subtract the round and the pre-money view of the same deal is $1.3B .
The valuation holds until the next priced round or secondary sale. A private company founded in 2016 with roughly 201 people has no daily price and no order book between rounds.
Lead investors for each round are in the funding timeline.
The closest biotechnology / drug discovery peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Formation Bio is a private company; its shares do not trade on a public exchange.
The last valuation is $1.7B.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
